(CNN) -- The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time, SciGen ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

SciGen Pharmaceuticals has voluntary recalled certain lots of the angiotensin II receptor blocker (ARB) irbesartan, owing to the presence of N-nitrosodiethylamine (NDEA), a probable human carcinogen, ...

Lawyers for consumers who claim harm from tainted versions of the blood pressure-lowering drug valsartan want to expand litigation to include at least two other drugs, losartan and irbesartan. Dozens ...

Certain lots of a blood pressure medication have been recalled because they may contain an impurity believed to cause cancer, the U.S. Food and Drug Administration announced Tuesday. Some Irbesartan ...

OTTAWA, March 13, 2019 /CNW/ - Health Canada is advising Canadians that Pro Doc Limitée is voluntarily recalling two lots of irbesartan tablets because of a nitrosamine impurity, N-nitrosodiethylamine ...

Nov. 2 (UPI) --A pharmaceutical company is recalling a blood pressure medication because it could contain an impurity scientists believe could cause cancer. ScieGen Pharmaceuticals announced the ...

UPDATE (June 15, 2021): Sanofi Consumer Health Inc. recalls 12 lots of irbesartan drugs due to azido impurity Sanofi Consumer Health Inc. is recalling 12 lots of prescription irbesartan tablets (brand ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The US Food and Drug Administration is ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The US Food and Drug Administration is ...

FDA tests showed that the recalled lots of these drugs contained N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials ...